Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1-Reference-Cited by-同舟云学术

Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

Published:1999-12-16 Issue:25 Volume:341 Page:1874-1881
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Starr Stuart E.,Fletcher Courtney V.,Spector Stephen A.,Yong Florence H.,Fenton Terence,Brundage Richard C.,Manion Douglas,Ruiz Nancy M.,Gersten Merril,Becker Mark,McNamara James,Purdue Lynette,Siminski Suzanne,Graham Bobbie,Kornhauser David M.,Fiske William,Vincent Carol,Lischner Harold W.,Dankner Wayne M.,Flynn Patricia M.,Mofenson Lynne M.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199912163412502

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus;The Journal of Infectious Diseases;2021-12-28

2. Impact of CYP2B6 genotype, TB therapy and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age;AIDS;2021-12-06

3. Frequent development of broadly neutralizing antibodies in early life in a large cohort of HIV-infected children;2021-05-07

4. The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long‐Term ARV Treatment;New Directions for Child and Adolescent Development;2020-05

5. Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study;The Lancet HIV;2019-04